Cell-penetrating peptide-mediated delivery of TALEN proteins via bioconjugation for genome engineering - Wikidata - wikimedia - TriplyDB

Cell-penetrating peptide-mediated delivery of TALEN proteins via bioconjugation for genome engineering

Cell-penetrating peptide-mediated delivery of TALEN proteins via bioconjugation for genome engineering

http://www.wikidata.org/entity/Q28538875

about

In Vivo Delivery Systems for Therapeutic Genome Editing Genome-editing Technologies for Gene and Cell Therapy Strategies for precision modulation of gene expression by epigenome editing: an overview Progress and prospects of engineered sequence-specific DNA modulating technologies for the management of liver diseases Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing in vitro and in vivo Highly efficient RNA-guided genome editing in human cells via delivery of purified Cas9 ribonucleoproteins.Gene disruption by cell-penetrating peptide-mediated delivery of Cas9 protein and guide RNA.The Argi system: one-step purification of proteins tagged with arginine-rich cell-penetrating peptides.Targeted gene knock-in by homology-directed genome editing using Cas9 ribonucleoprotein and AAV donor delivery.TALEN based HPV-E7 editing triggers necrotic cell death in cervical cancer cells RNA-directed gene editing specifically eradicates latent and prevents new HIV-1 infection.Synthetic zinc finger proteins: the advent of targeted gene regulation and genome modification technologies.Novel lentiviral vectors with mutated reverse transcriptase for mRNA delivery of TALE nucleases Engineering synthetic TALE and CRISPR/Cas9 transcription factors for regulating gene expression Damaging the Integrated HIV Proviral DNA with TALENs.Can genome engineering be used to target cancer-associated enhancers?Improved cell-penetrating zinc-finger nuclease proteins for precision genome engineering Direct protein delivery to mammalian cells using cell-permeable Cys2-His2 zinc-finger domains.Genome editing strategies: potential tools for eradicating HIV-1/AIDS.Protein delivery using Cys2-His2 zinc-finger domains.Reactivation of Latent HIV-1 Expression by Engineered TALE Transcription Factors.Homology-directed repair in rodent zygotes using Cas9 and TALEN engineered proteins.Controlled delivery of β-globin-targeting TALENs and CRISPR/Cas9 into mammalian cells for genome editing using microinjection Streptococcus thermophilus CRISPR-Cas9 Systems Enable Specific Editing of the Human Genome Protein Delivery of an Artificial Transcription Factor Restores Widespread Ube3a Expression in an Angelman Syndrome Mouse Brain Membrane Oxidation Enables the Cytosolic Entry of Polyarginine Cell-penetrating Peptides.HIV-1 Latency and Eradication: Past, Present and Future Efficient therapeutic delivery by a novel cell-permeant peptide derived from KDM4A protein for antitumor and antifibrosis.The Development of TALE Nucleases for Biotechnology.Precision genome editing: a small revolution for glycobiology.TALEN-mediated genome editing: prospects and perspectives.A practical guide to induced pluripotent stem cell research using patient samples.Technology developments in biological tools for targeted genome surgery.Sequence-defined shuttles for targeted nucleic acid and protein delivery.TALEN-mediated genome engineering to generate targeted mice.Synthetic epigenetics-towards intelligent control of epigenetic states and cell identity Virus-Like Particles Derived from HIV-1 for Delivery of Nuclear Proteins: Improvement of Production and Activity by Protein Engineering.Non-viral delivery of genome-editing nucleases for gene therapy.TALEN gene editing takes aim on HIV.Use of genome-editing tools to treat sickle cell disease.

P2860

Q26748886-85F6213F-FD41-46AC-990F-73C937009A81 Q26769662-57BEFFAD-1CAE-45A1-ABAC-D797FEF22BED Q26782876-18D6E9C5-22BC-4FA3-B9E6-23E5EB330509 Q27011249-5D7B9C67-AE5B-4CCE-8BD4-7B2EE74BF4E9 Q30614255-60A2D037-B324-4E2A-BF4B-C036B4B70C77 Q33657682-DC0D072C-9607-41EB-821B-31686F631097 Q33657689-DAC11BD9-18BF-47D8-90DA-35C728885417 Q33752853-4923E47D-83FB-487F-9469-ED31BEB32E53 Q33878793-3736FEF8-8499-4CB2-B227-4C5300CAAAC7 Q33905878-AF5154F4-8D72-4BFF-98A0-2172CD95CFBB Q34025414-FB4D31AC-FA9F-4C73-A99A-1D818E326C3D Q34070213-78312F0A-104B-4AE8-8B40-92347CA795AA Q34200828-F512E9F7-FF1A-42EF-A017-02F1DF8367F8 Q34243548-445B45DA-AFE3-4E24-BFB0-135BC89F448D Q34475249-4C1EE797-BD02-40E8-87CD-D60333D1D450 Q34652242-47475A4D-0900-4B2F-A24F-CF6B6AD776C9 Q35161372-86A2E95A-E074-44E7-AD97-D0A85FD7576E Q35461043-E35FA0D3-96E1-4E90-BDF3-F48EB63A41E5 Q35612053-7785075A-FCA0-44E4-995A-C757BB85F12D Q35900519-FB4A15D9-60DC-40FF-96AA-6C40270B7CE8 Q35942658-9F086869-DA60-4C52-828C-930123A0EB4E Q36128900-073F918A-FE11-4E55-AD51-E42A4F02E527 Q36272492-957F993E-EBE3-4585-A676-684E60CBF272 Q36675308-B171AAFB-48AD-4BAB-BFA7-9F687369D3F2 Q36675332-BBB1C74A-30AE-4270-8E7F-BB510D8560B0 Q36778764-B45E5FA9-DEF8-4D55-BD11-CAF828EBAB6E Q37505823-78EA3019-6615-4031-A91D-95337A25A0C6 Q37580169-5471EC88-E9C9-4FF0-981C-838908750D98 Q37652116-117F47AE-BCCF-4FE9-958D-1A0AB45B27BA Q38214809-E97DC49B-4859-44C1-9EF9-F32D38283B48 Q38233430-18744B36-E035-4135-85FD-8BBEE8F83E0E Q38236662-6990651A-782B-4572-A33C-2A080905FAB7 Q38254476-169A668F-B4C0-4150-86CE-B2F068E43EDB Q38265619-1A046105-EF70-4DE3-B6F9-E7CBD8AE94EE Q38321956-E5CA813F-443B-4477-8D49-CE8BDCC1453A Q38367820-569E98DB-790D-4945-BEA7-58BD5B063BF4 Q38731982-9C86C3B3-4147-43AF-96D1-1F701AD81C34 Q38802151-2FD10FF2-EB5F-4951-B88F-AF7362D5DA88 Q38832507-13CD68CA-C940-4921-87CD-E31C3D3BF582 Q38850483-966255E9-A003-4E5C-A6A7-3F30D2A9A5A7

P2860

Cell-penetrating peptide-mediated delivery of TALEN proteins via bioconjugation for genome engineering

http://www.wikidata.org/entity/Q28538875

description

2014 nî lūn-bûn

@nan

2014 թուականին հրատարակուած գիտական յօդուած

@hyw

2014 թվականին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Cell-penetrating peptide-media ...... ugation for genome engineering

@ast

Cell-penetrating peptide-media ...... ugation for genome engineering

@en

Cell-penetrating peptide-media ...... ugation for genome engineering

@nl

type

label

Cell-penetrating peptide-media ...... ugation for genome engineering

@ast

Cell-penetrating peptide-media ...... ugation for genome engineering

@en

Cell-penetrating peptide-media ...... ugation for genome engineering

@nl

prefLabel

Cell-penetrating peptide-media ...... ugation for genome engineering

@ast

Cell-penetrating peptide-media ...... ugation for genome engineering

@en

Cell-penetrating peptide-media ...... ugation for genome engineering

@nl

P1433

Q28538875-05BD8659-34F5-4A59-87C1-12392DB7762D

P1476

Q28538875-E6ED8A04-E08F-4213-A1A0-0DCC9730C41A

P2093

Q28538875-47BC2CE3-B937-4746-BC49-08D70650326B

Q28538875-7DD8537A-8B91-4830-8C6D-4535AEE18455

Q28538875-8A9BC816-1C6B-4782-923F-416B97521180

Q28538875-CD1FCAE0-B6D5-4EEF-BB1F-FC40A439B4D8

P2860

Q28538875-0C5A8384-E661-4C91-9DBE-4EC100123DEC

Q28538875-0D64B537-B6E2-43E6-A205-37F54117B275

Q28538875-107693B4-22DE-4A84-9F78-1200617D0F9F

Q28538875-139E3507-F4E8-4FF3-BF41-15854D0619FF

Q28538875-16AB522A-E59B-41F6-8B65-4961FE654E4E

Q28538875-1928F26D-E9F0-4E74-99CD-137291F5AA9A

Q28538875-27461212-75E9-4712-8F12-EC77F592D37D

Q28538875-2852A3C7-B39C-4A9C-92DD-1EBE7E17FAA2

Q28538875-2A81AB06-8974-4B55-8772-59BC2A5F77A4

Q28538875-2A9D0C2B-D85D-4821-B4D3-5554608C13D3

P304

Q28538875-EF427060-EF0F-4206-86EE-CF4D79F13C6A

P31

Q28538875-FBD0B9FE-09B0-459A-A112-1EB94D748741

P3181

Q28538875-9D0FF566-9C78-46D4-9109-4F9AB577D247

P356

Q28538875-581CA9F1-31A1-480A-A936-891365EF416E

P407

Q28538875-78996F7D-A2E5-447D-B446-C90F398A7BE2

P433

Q28538875-2BC80A85-9095-42A3-A203-AA7765BDA801

P478

Q28538875-FA7E7C63-E1EF-4383-8B28-435E4B48ED79

P50

Q28538875-A7AA86A5-D09B-410A-9678-71B8D1DA709D

P577

Q28538875-6F18789B-01F0-487E-8073-D2CB95C06987

P5875

Q28538875-F7A62EE0-5179-4830-B19F-D02691E11EAE

P698

Q28538875-D834C5CA-71A4-461C-8986-5CBA9A532287

P921

Q28538875-D5F1209A-8B2B-4210-8F0A-DFD4243F8DA5

P932

Q28538875-1F45D8AF-362F-4533-B808-36F3D3472EE0

P3181

P356

JOURNAL.PONE.0085755

P1433

P1476

Cell-penetrating peptide-media ...... ugation for genome engineering

@en

P2093

Carlos F Barbas

http://www.w3.org/2001/XMLSchema#string

Jia Liu

http://www.w3.org/2001/XMLSchema#string

Shannon J Sirk

http://www.w3.org/2001/XMLSchema#string

Thomas Gaj

http://www.w3.org/2001/XMLSchema#string

P2860

RNA-guided human genome engineering via Cas9

T cell-specific siRNA delivery suppresses HIV-1 infection in humanized mice

Multiplex genome engineering using CRISPR/Cas systems

Efficient genome editing in zebrafish using a CRISPR-Cas system

Knockout rats via embryo microinjection of zinc-finger nucleases

Targeted gene inactivation in zebrafish using engineered zinc-finger nucleases

Heritable targeted gene disruption in zebrafish using designed zinc-finger nucleases

The Crystal Structure of TAL Effector PthXo1 Bound to Its DNA Target

Structural Basis for Sequence-Specific Recognition of DNA by TAL Effectors

Structure of the AvrBs3–DNA complex provides new insights into the initial thymine-recognition mechanism

P304

e85755

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2044790

http://www.w3.org/2001/XMLSchema#string

P356

10.1371/JOURNAL.PONE.0085755

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

James T Patterson

P577

2014-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259920124

http://www.w3.org/2001/XMLSchema#string

P698

24465685

http://www.w3.org/2001/XMLSchema#string

P921

P932

3896395

http://www.w3.org/2001/XMLSchema#string